- Home
- ASM vs BIOA Comparison
ASM vs BIOA Comparison
Compare ASM & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASM | BIOA |
|---|---|---|
| Founded | 1968 | 2015 |
| Country | Canada | United States |
| Employees | N/A | 62 |
| Industry | Metal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 920.7M | 757.0M |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | ASM | BIOA |
|---|---|---|
| Price | $6.36 | $17.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | $8.18 | ★ $51.50 |
| AVG Volume (30 Days) | ★ 4.3M | 399.0K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $53.35 | $720.93 |
| Revenue Next Year | $34.26 | N/A |
| P/E Ratio | $67.93 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.09 | $3.79 |
| 52 Week High | $11.99 | $24.00 |
Technical Indicators
Market Signals| Indicator | ASM | BIOA |
|---|---|---|
| Relative Strength Index (RSI) | 40.12 | 49.39 |
| Support Level | $3.96 | $15.59 |
| Resistance Level | $6.54 | $18.65 |
| Average True Range (ATR) | 0.38 | 1.30 |
| MACD | -0.02 | 0.13 |
| Stochastic Oscillator | 0.29 | 45.91 |
Price Performance
Historical ComparisonAbout ASM Avino Silver & Gold Mines Ltd. (Canada)
Avino Silver & Gold Mines Ltd is a mineral resource company. It is engaged in the exploration, extraction, and processing of silver, gold, and copper and the acquisition, exploration, and advancement of mineral properties. The company generates majority of its revenues through the sale of Copper produced from its mines. Its project portfolio includes Avino; San Gonzalo; Oxide Tailings; Bralorne Gold and others.
About BIOA BioAge Labs Inc.
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The company's technology platform and differentiated human datasets enable the identification of targets based on insights into molecular changes that drive aging. The Company operates and manages its business as one reportable and operating segment, which is the business of extending healthy human life by targeting molecular causes of aging.